Assessment of Oral and Nasal Breathing With Sensors Analyzing Algorithm

NCT ID: NCT05869071

Last Updated: 2023-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-23

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about the agreement between sensors analyzing algorithm and body plethysmography in measuring oral and nasal breathing in healthy adults, and in patients with chronic rhinosinusitis, asthma and chronic obstructive pulmonary disease. The main question it aims to answer is: • Is the algorithm-based method accurate enough in analyzing respiratory obstruction as compared to body plethysmography (reference method)? Participants will perform a short breathing protocol (oral and nasal breathing with different masks) during which time their breathing is monitored with both methods.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The data collected in the Patient Registry include: Parameters on general health, like previous illnesses, medications, height, weight, answers to symptoms queries and queries on quality of life (Asthma test, COPD test, Sinonasal Outcome Test 22) as well as results from the examined medical devices (body plethysmography, spirometry, sensors analyzing algorithm).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nasal Polyps Asthma COPD Allergic Rhinitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy volunteers

Participants with no chronic disease and no acute symptoms

Sensor analyzing software (own development)

Intervention Type DEVICE

A software the research group developed. Analyzes acoustic and accelerator signals to measure airway obstruction.

Body plethysmograph

Intervention Type DEVICE

Body plethysmograph measures specific airway resistance

Patients with Allergic rhinitis or Nasal Polyps

Participants with allergic rhinitis or nasal polyps

Sensor analyzing software (own development)

Intervention Type DEVICE

A software the research group developed. Analyzes acoustic and accelerator signals to measure airway obstruction.

Body plethysmograph

Intervention Type DEVICE

Body plethysmograph measures specific airway resistance

Patients with asthma

Participants with asthma

Sensor analyzing software (own development)

Intervention Type DEVICE

A software the research group developed. Analyzes acoustic and accelerator signals to measure airway obstruction.

Body plethysmograph

Intervention Type DEVICE

Body plethysmograph measures specific airway resistance

Patients with COPD

Participants with Chronic Obstructive Pulmonary Disease

Sensor analyzing software (own development)

Intervention Type DEVICE

A software the research group developed. Analyzes acoustic and accelerator signals to measure airway obstruction.

Body plethysmograph

Intervention Type DEVICE

Body plethysmograph measures specific airway resistance

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sensor analyzing software (own development)

A software the research group developed. Analyzes acoustic and accelerator signals to measure airway obstruction.

Intervention Type DEVICE

Body plethysmograph

Body plethysmograph measures specific airway resistance

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ganshorn PowerCube body+ plethysmograph

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 5 healthy and asymptomatic volunteers with regard to lungs and nose
* 5 patients with allergic rhinitis or nasal polyps (diagnosis of allergic rhinitis confirmed by a PRICK test or specific Ig E antibody tests and Nasal polyposis diagnosed by an ENT specialist, with endoscopy)
* 5 patients with asthma (diagnosis of asthma based on peak expiratory flow (PEF) monitoring, spirometry, or other appropriate objective measurement methods performed by a pulmonologist
* 5 patients with Chronic Obstructive Pumonary Disease (diagnosis of COPD based on spirometry (post-bronchodilator Forced Expiratory Volume/ Forced Vital Capacity (FEV1/FVC) ratio below 0.70)

Exclusion Criteria

* Pregnancy.
* History of surgical procedures in the chest, larynx, throat (excluding tonsillectomy), or nasal area.
* Recent illnesses or surgeries that pose a risk to the patient or prevent proper measurement (common contraindications for spirometry):
* Recent (\<1 month) myocardial infarction.
* Severe coronary artery disease with easily triggered symptoms.
* Cerebral artery aneurysm.
* Recent brain (\<4 weeks) or eye (\<1 week) surgery.
* Severe cardiac arrhythmias.
* Pulmonary tuberculosis.
* Pneumothorax
* Immediate postoperative period of lung surgery (\<1 day).
* Dementia or confusion.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oulu University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Olli-Pekka Alho, MD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olli-Pekka Alho, Prof

Role: PRINCIPAL_INVESTIGATOR

University of Oulu, Finland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oulu University Hospital

Oulu, , Finland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Finland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paulus Tokola, MD

Role: CONTACT

+35883152011

Olli-Pekka Alho, Prof

Role: CONTACT

+35883152011

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Paulus Tokola, MD

Role: primary

+358-8-315 2011

Olli-Pekka Alho

Role: backup

+35883152011

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

126/2021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.